Key Insights

Highlights

Treatment Research

19 treatments under study, led by Nebivolol Pliva 5 Mg Tablete

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
SYFd13707b2ef764c26a3a85ae6e776a4b4Phase 3Unknown

Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK)

Showing all 1 trials

Research Network

Common Treatments

  • Nebivolol Pliva 5 Mg Tablete1
  • Bisoprolol Orion 25 Mg Tabletter1
  • Bisoprolol Orion 10 Mg Tabletit1
  • Carvedilol Stada 125 Mg Töflur1
  • Carvedilol Stada 25 Mg Töflur1

Active Sponsors

  • Frederiksberg Hospital1

Activity Timeline